Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder.
Hematuria
Prostate cancer
Recurrence
Transurethral resection
Journal
Urology case reports
ISSN: 2214-4420
Titre abrégé: Urol Case Rep
Pays: United States
ID NLM: 101626357
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
11
09
2020
accepted:
20
09
2020
entrez:
26
10
2020
pubmed:
27
10
2020
medline:
27
10
2020
Statut:
epublish
Résumé
A 74-year-old male patient with stage D1 prostate cancer with the initial prostate-specific antigen (PSA) level of 5570 ng/mL had received androgen deprivation therapy and the serum PSA level had decreased to 0.23 ng/mL when he developed macroscopic hematuria. MRI and cystoscopy suggested invasive urothelial cancer of the bladder, and transurethral resection was performed. The tumors were pathologically diagnosed as a Gleason score 9 prostate cancer with no PSA expression. Prostate cancer patients who develop novel symptoms should be screened for prostate cancer recurrence even if they have very low PSA levels.
Identifiants
pubmed: 33102118
doi: 10.1016/j.eucr.2020.101421
pii: S2214-4420(20)30310-7
pmc: PMC7574274
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101421Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
We have no conflict of interest to declare.
Références
J Cell Biochem. 2004 Oct 1;93(2):233-41
pubmed: 15368351
Cancer. 2007 Jan 15;109(2):198-204
pubmed: 17171704
Br J Cancer. 2017 Jun 6;116(12):1520-1525
pubmed: 28449007
Hum Pathol. 2019 Jul;89:99-108
pubmed: 31054895
Cancer. 1996 Mar 1;77(5):934-40
pubmed: 8608487